Top Markets
#1 ADO Protocol ADO Protocol +193.36%
#2 Islamic Coin Islamic Coin +155.22%
#3 GoPlus Security GoPlus Security +45.23%
#4 Siren Siren +42.82%
#5 GAIB AID GAIB AID +24.80%
#6 Casper Network Casper Network +19.86%
#7 Starpower Starpower +15.89%
#8 Verus Coin Verus Coin +13.74%
#9 o1.exchange o1.exchange +12.92%
#10 Pons Pons +12.30%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Chembio Diagnostics, Inc. Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc.

CEMI
Classement en actions #33406
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in... Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections. These diagnostic tools are sold under well-known brand names including STAT-PAK, SURE CHECK, STAT VIEW, and DPP. Chembio distributes its products directly and through various partners to a diverse global customer base. This clientele includes medical laboratories, hospitals, government and public health agencies, non-governmental organizations (NGOs), medical professionals, and retail outlets across the United States and worldwide. The company engages in strategic partnerships with prominent organizations such as the Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics. Additionally, Chembio collaborates with several key U.S. government entities, including the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture (USDA). Founded in 1985, Chembio Diagnostics, Inc. has its headquarters located in Hauppauge, New York.
Prix de l'action
$0.455
Dernière synchronisation: 2023-04-27
Capitalisation boursière
$7.70M
Changement (1 jour)
0.22%
Changement (1 an)
0.00%
Pays
US
Échange Chembio Diagnostics, Inc. (CEMI)

Catégorie

Healthcare
Bénéfices pour Chembio Diagnostics, Inc. (CEMI)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Chembio Diagnostics, Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Chembio Diagnostics, Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
$7.61B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
$4.76B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
$-252.70M -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
$1.42B -
US